Publications by authors named "Hua-Hua Yang"
World J Clin Cases
June 2022
Article Synopsis
- - The study aimed to compare the effectiveness and safety of two treatments for Crohn's disease: Adalimumab (ADA) and Infliximab (IFX) through a meta-analysis of fourteen cohort studies.
- - Results showed no significant differences in clinical outcomes like response rates, remission, and loss of response between ADA and IFX; both treatments had similar effectiveness.
- - However, ADA was associated with fewer overall adverse events compared to IFX, suggesting it might be a safer option for patients.
